Literature DB >> 28624326

Randomized Trial on Illuminated-Microcatheter Circumferential Trabeculotomy Versus Conventional Trabeculotomy in Congenital Glaucoma.

Jyoti Shakrawal1, Shveta Bali2, Talvir Sidhu1, Saurabh Verma1, Ramanjit Sihota1, Tanuj Dada3.   

Abstract

PURPOSE: To compare 1-year outcomes of illuminated microcatheter-assisted circumferential trabeculotomy (IMCT) vs conventional partial trabeculotomy (CPT) for primary congenital glaucoma (PCG).
DESIGN: Randomized clinical trial.
METHODS: Forty eyes of 31 patients with unilateral or bilateral primary congenital glaucoma aged less than 2 years were randomized to undergo IMCT (20 eyes) or CPT (20 eyes). Primary outcome measure was intraocular pressure (IOP) reduction. The success criterion was defined as IOP ≤ 12 mm Hg without and with antiglaucoma medications (absolute success and qualified success, respectively).
RESULTS: The mean age of our study population was 8.35 ± 1.2 months. The mean preoperative IOP was 24.70 ± 3.90 mm Hg in the IMCT group and 24.60 ± 3.31 mm Hg in the CPT group. Both groups were comparable with respect to preoperative IOP, corneal clarity, corneal diameter, vertical cup-to-disc ratio, and refractive error. In the IMCT group, 360-degree cannulation was achieved in 80% (16/20) of eyes. For the IMCT group and CPT groups, respectively, the absolute success rates were 80% (16/20) and 60% (12/20) (P < .001) and qualified success rates were 90% (18/20) and 70% (14/20) (P < .001). Both procedures produced a statistically significant reduction in IOP, and eyes undergoing IMCT achieved a lower IOP than CPT group eyes at 12 months follow-up (9.5 ± 2.4 mm Hg and 11.7 ± 2.1 mm Hg, respectively, P < .001).
CONCLUSION: In primary congential glaucoma, illuminated microcatheter-assisted 360-degree circumferential trabeculotomy performed better than conventional partial trabeculotomy at 1 year follow-up and resulted in significantly lower IOP measurements.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28624326     DOI: 10.1016/j.ajo.2017.06.004

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  8 in total

1.  Viscocanalostomy combined with nearly 360-degree suture trabeculotomy for the treatment of primary congenital glaucoma: a preliminary report of a novel technique for trabeculotomy.

Authors:  Ya Liang; Qiuli Yu; Fangfang Ji; Hong Sun; Zhilan Yuan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-11-30       Impact factor: 3.117

2.  Ab Interno vs. Ab Externo Microcatheter-Assisted Circumferential Trabeculotomy in Treating Patients With Primary Open-Angle Glaucoma.

Authors:  Weijia Zhang; Yiwei Wang; Chen Xin; Yang Sun; Kai Cao; Huaizhou Wang; Ningli Wang
Journal:  Front Med (Lausanne)       Date:  2021-12-20

3.  Microcatheter-assisted circumferential trabeculotomy in primary congenital glaucoma.

Authors:  Shaaban A M Elwan; Raafat M A Abdallah; Ahmed S Abdelhalim
Journal:  Saudi J Ophthalmol       Date:  2022-02-18

4.  Surgical interventions for primary congenital glaucoma.

Authors:  Meghal Gagrani; Itika Garg; Deepta Ghate
Journal:  Cochrane Database Syst Rev       Date:  2020-08-25

Review 5.  Update in Genetics and Surgical Management ofzzm321990Primary Congenital Glaucoma

Authors:  Mehmet C Mocan; Amy A Mehta; Ahmad A Aref
Journal:  Turk J Ophthalmol       Date:  2019-12-31

Review 6.  Microcatheter-Assisted Circumferential Trabeculotomy versus Conventional Trabeculotomy for the Treatment of Childhood Glaucoma: A Meta-analysis.

Authors:  Ling Ling; Kaibao Ji; Ping Li; Zhe Hu; Yiqiao Xing; Yifeng Yu; Wentian Zhou
Journal:  Biomed Res Int       Date:  2020-11-04       Impact factor: 3.411

7.  Microcatheter-Assisted Circumferential Trabeculotomy in Primary Congenital Glaucoma: Long-Term Clinical Outcomes.

Authors:  Luigi Fontana; Alberto Neri
Journal:  J Clin Med       Date:  2022-01-14       Impact factor: 4.241

8.  Circumferential (360°) trabeculotomy in primary congenital glaucoma: 19-245 months of follow-up.

Authors:  Turid Skei Tønset; Jan Erik Jakobsen; Jon Henrik Tveit; Anna-Katharina L Jørstad; Tone Beate Brevik; Lotte-Guri Bogfjellmo Sten; Liv Drolsum
Journal:  Acta Ophthalmol       Date:  2021-03-19       Impact factor: 3.988

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.